ALNYALNYLAM PHARMACEUTICALS, INC.
Health Care
Stockholders' Equity Attributable to Parent revised up 121.6% for Q3 2025
This is the 3rd largest revision in ALNY's history.
Stockholders' Equity Attributable to Parent·As of Jun 30, 2025
Major restatement$555.3M▲ 121.6%
was$250.6M
Revised up in a 10-Q.
Verify against SEC filingsShow
As reported$250.6M
Accepted 2025-07-310001178670-25-000090
Restated$555.3M
Accepted 2026-10-290001178670-26-000076
StockholdersEquity · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time ALNY — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.